Status:
COMPLETED
Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients
Lead Sponsor:
China Medical University Hospital
Conditions:
Stroke
Middle Cerebral Artery Infarction
Eligibility:
All Genders
35-70 years
Phase:
PHASE2
Brief Summary
The objective of the study is to determine the efficacy of brain transplants of CD34+ stem cells obtained from peripheral blood of patients in the treatment of chronic stroke patients.
Detailed Description
30 patients are divided into 2 groups, one treatment group and one control group.Treatment group will be implanted with peripheral blood stem cell and receive convention stroke therapy ,and control gr...
Eligibility Criteria
Inclusion
- aged 35-70 chronic stroke adult patient,
- with stroke history of more than 6 months, less than 60 months，
- with stable hemiplegia condition, and
- NIHSS (NIH Stroke Scale) score is between 9-20.
Exclusion
- patients aged less than 35 or more than 70,
- hemorrhage stroke or MRI show the occlusion is not in the middle cerebral artery territory，NIHSS is not in the range of 9-20,
- pregnant women,
- impaired liver function, abnormal blood coagulation, AIDS, combine other tumor or special condition.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00950521
Start Date
June 1 2009
End Date
December 1 2010
Last Update
April 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan